Successful Embolization of Type II Congenital Extrahepatic Portosystemic Shunt Using Amplatzer Septal Occluder and Amplatzer Vascular Plug II

Abstract Acquired and congenital left ventricular to right atrial communication is rare, but nowadays, the frequency of the iatrogenic subgroup is increasing. Successful transcatheter closure of these defects with different devices has been reported. Herein, we presented successful closure of left ventricular to right atrial communication with Amplatzer Duct Occluder 2 after attempting to close with a failed Amplatzer Vascular Plug II device in a 7-year-old girl. This report supports that transcatheter closure of iatrogenic Gerbode defect with Amplatzer Duct Occluder 2 device is safe and effective.

Download Full-text

Endovascular Embolization of a Large High-Flow Splenic Arteriovenous Fistula and Aneurysm Using the Amplatzer Vascular Plug II

Annals of Vascular Surgery ◽

10.1016/j.avsg.2015.09.012 ◽

2016 ◽

Vol 31 ◽

pp. 210.e1-210.e3 ◽

Cited By ~ 1

Author(s):

Mario D'Amico ◽

Roberto Miraglia ◽

Settimo Caruso ◽

Luigi Maruzzelli ◽

Kelvin Cortis ◽

...

Keyword(s):

Arteriovenous Fistula ◽

Endovascular Embolization ◽

High Flow ◽

Amplatzer Vascular Plug ◽

Vascular Plug ◽

Splenic Arteriovenous Fistula ◽

Amplatzer Vascular Plug Ii

Download Full-text

Hemodialysis Arteriovenous Access Occlusion Using the Amplatzer Vascular Plug in Patients with Intractable Arm Edema

Case Reports in Nephrology and Dialysis ◽

10.1159/000477663 ◽

2017 ◽

Vol 7 (2) ◽

pp. 63-72

Author(s):

Michele Di Filippo ◽

Danilo Barbarisi ◽

Doriana Ferrara ◽

Stefania Brancaccio ◽

Luca del Guercio ◽

...

Keyword(s):

Vascular Occlusion ◽

Amplatzer Vascular Plug ◽

Type Ii ◽

Vascular Plug ◽

Jude Medical ◽

The Third ◽

Hand Ischemia ◽

Type Iv ◽

Arteriovenous Access ◽

Steal Syndrome

Objectives: Vascular occlusion of hemodialysis arteriovenous access (AVA) using an Amplatzer vascular plug (AVP; St. Jude Medical, St. Paul, MN, USA) is an arising and alternative practice in selected patients; however, few reported cases can be found in the literature. Herein, we report on our experience with endovascular treatment of complicated AVA. Materials and Methods: From September 2015 to December 2016, 3 patients at our clinic underwent an occlusion of hemodialysis AVA with 2 different Amplatzer vascular plugs: 2 patients with type II and 1 patient with type IV. Of these, 1 patient was treated for an autologous radiocephalic fistula, the second patient was treated for an autologous brachiocephalic fistula located at the elbow, and the third was, instead, treated for a radiocephalic forearm fistula. The reason for closing the AVA in all patients was due to the presence of dialysis-associated steal syndrome with critical hand ischemia and intractable ipsilateral edema. Results: All AVAs were treated using an AVP. No plug migration, access revascularization, persistent ischemia, nor other complications were observed. Conclusion: This report suggests that the use of AVP for embolization of complicated AVA is a safe and reasonable alternative to open surgery in selected patients.

Download Full-text

The amplatzer vascular plug and amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.22370 ◽

2009 ◽

Vol 76 (3) ◽

pp. 411-417 ◽

Cited By ~ 34

Author(s):

Matthew Schwartz ◽

Andrew C. Glatz ◽

Jonathan J. Rome ◽

Matthew J. Gillespie

Keyword(s):

Cardiovascular Disease ◽

Vascular Occlusion ◽

Amplatzer Vascular Plug ◽

Vascular Plug ◽

Amplatzer Vascular Plug Ii

Download Full-text

Comparison of Surgical Ligation and Endovascular Embolization in the Management of Type II Congenital Extrahepatic Portosystemic Shunt: A Retrospective Clinical Study

10.21203/rs.3.rs-184047/v1 ◽

2021 ◽

Author(s):

Jin-long Zhang ◽

Wei Dong Duan ◽

Zhu Ting Fang ◽

Mao Qiang Wang ◽

Li Cui ◽

...

Keyword(s):

Endovascular Embolization ◽

Portosystemic Shunt ◽

Type Ii ◽

Intraoperative Blood Loss ◽

Procedure Time ◽

Surgical Ligation ◽

Post Procedure ◽

Congenital Extrahepatic Portosystemic Shunt ◽

Interventional Group ◽

Surgical Group

Abstract Background: Surgical ligation and endovascular embolization have been recommended for type II congenital extrahepatic portosystemic shunt (CEPS); however, no consensus has been reached. This study was designed to compare the safety and efficacy of surgical ligation and endovascular embolization for the treatment of type II CEPS. Methods: In this retrospective study, 23 consecutive patients diagnosed with type II CEPS between March 2011 and April 2019 were divided into either a surgical group (n=13; 41.5±19.9years) or the interventional group (n =10; 44.9±19.7years). The surgical group underwent laparoscopic surgical ligation of the shunt alone or ligation of the shunt and splenic artery and/or vein. The interventional group underwent endovascular embolization using microcoils, detachable coils and vascular plug. Results: All 23 patients received a one-step shunt closure, and their clinical symptoms were significantly improved within 3 months post-procedure and without recurrence during follow-up. The serum ammonia levels in both groups decreased after the procedure and dropped to normal level at 6 to 12 months post-procedure. Compared with baseline, the portal vein diameter in interventional group increased significantly at 3-, 6-, 12-, and 36-month post-occlusion (P=0.01 for all). The procedure time was shorter in interventional group (127.0±43.2minutes) than surgical group (219.8±56.7minutes; P <0.001). The intraoperative blood loss in interventional group (32.0±62.5mL) was less than that in surgical group (238.5±396.9mL; P=0.001).Conclusion: Both surgical ligation and endovascular embolization are effective in the treatment of type II CEPS. Endovascular embolization has the advantages of shorter procedure time, and less intraoperative blood loss. The ligation of the portosystemic shunt and splenic artery and vein is feasible with apparent safety, and it could avoid a second surgical treatment.

Download Full-text

Transcatheter closure of elongated and pulmonary hypertensive patent arterial duct in infants using Amplatzer vascular plug II

Cardiology in the Young ◽

10.1017/s1047951120000104 ◽

2020 ◽

Vol 30 (2) ◽

pp. 243-248 ◽

Cited By ~ 1

Author(s):

Sneha M. Jain ◽

Priya M. Pradhan ◽

Supratim Sen ◽

Bharat V. Dalvi

Keyword(s):

Pulmonary Artery ◽

Amplatzer Vascular Plug ◽

Successful Outcome ◽

Pulmonary Artery Stenosis ◽

Amplatzer Duct Occluder ◽

Vascular Plug ◽

Arterial Duct ◽

Duct Diameter ◽

Patent Arterial Duct ◽

Amplatzer Vascular Plug Ii

AbstractObjective:To evaluate the feasibility, efficacy, and safety of Amplatzer vascular plug II in large and elongated ducts in infants.Introduction:Patent arterial duct device closure is technically challenging in infants with large and elongated ducts because Amplatzer duct occluder and Amplatzer duct occluder II have high chances of causing aortic coarctation and left pulmonary artery stenosis, respectively. The Amplatzer vascular plug II being soft with no retention discs on either sides helps in mitigating these problems.Method:This is a prospective, observational study involving infants with clinical, echocardiographic and angiographic evidence of large left to right shunt. All the children underwent duct closure using Amplatzer vascular plug II.Results:Eighteen infants qualified for the study. Mean age and weight were 8.63 ± 3.84 months and 6.3 ± 1.7 kg, respectively. The angiographic mean duct diameter at the pulmonary artery end was 4.66 ± 0.92 mm, and the mean duct length was 9.4 ± 2.48 mm. The size of Amplatzer vascular plug II used varied from 6 mm to 10 mm. Technical success was achieved in 16/18 cases. One patient had device embolisation, and in the other, the device was found to be unstable. The ratio of Amplatzer vascular plug II size to the duct diameter was 1.65 ± 0.27, while the ratio of ductal length to device length was 1.48 ± 0.46 in those with successful outcome.Conclusions:Amplatzer vascular plug II is a safe and effective option in appropriately selected infants with elongated ducts. Diameter and length of Amplatzer vascular plug II vis-a-vis those of the ductus are important determinants of the successful outcome.

Download Full-text